Viewing nowCombinationYumeron Tablet 20/5mg
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.

MFDS item code 202003955 · Approved 2020.05.28
Treatment of hypertension and hypercholesterolemia and reduction of cardiovascular disease risk
This medication is prescribed only for patients who must take Olmesartan Medoxomil for hypertension treatment and Rosuvastatin for dyslipidemia treatment simultaneously. Olmesartan Medoxomil helps effectively treat essential hypertension. Rosuvastatin is primarily used as an adjunct to dietary therapy for patients with primary hypercholesterolemia and mixed dyslipidemia, lowering LDL cholesterol levels and delaying atherosclerosis progression. Additionally, it is used as an adjunct in the treatment of familial hypercholesterolemia or dysbetalipoproteinemia. For patients at high risk of cardiovascular events, it helps reduce the risks associated with stroke, myocardial infarction, and vascular revascularization. Therefore, this medication is used to improve cardiovascular health by managing both hypertension and dyslipidemia simultaneously.
Olmesartan Medoxomil: The recommended initial dose is 10mg once daily, regardless of meals. If blood pressure is not adequately controlled, it may be increased to 20mg once daily, with a maximum dose of 40mg. It can be used in combination with diuretics such as hydrochlorothiazide. Rosuvastatin: The initial dose is 5mg once daily, which can be adjusted to a maintenance dose as needed. The maintenance dose is 1
Safety and efficacy for children under 18 years of age have not been established.
This medication can severely harm the fetus or newborn if taken during pregnancy, especially in the second and third trimesters, so it must be stopped immediately upon confirmation of pregnancy. Patients with allergies to any of the ingredients of this medication or alcohol intolerance, pregnant or potentially pregnant women, and nursing mothers should not take this medication. It is not safe for patients with severely impaired kidney function or on dialysis, severe liver dysfunction, bile duct obstruction, undiagnosed liver diseases, or muscular diseases to use this medication. Patients with a history of muscle-related diseases, alcohol abuse, the elderly, or specific genetic muscle disorders should exercise caution, as the risk of muscle injury increases with high doses. This medication contains lactose, so it should not be administered to patients with lactose intolerance or related genetic disorders. When initiating this medication in patients with reduced blood volume or low salt levels, hypotension may occur, thus careful monitoring is required. In patients whose kidney function is dependent on this medication or those with renovascular hypertension, it should be administered cautiously, with regular testing of potassium levels and kidney function through blood tests. Since this medication lowers blood pressure, dizziness may occur; therefore, it is advisable to avoid hazardous tasks such as working at heights or driving. Patients with a history of liver disease or excessive alcohol consumption are recommended to undergo liver function tests before and during the administration of this medication. If symptoms such as muscle pain, weakness, or spasms occur, notify medical personnel immediately, and necessary blood tests should be performed to check for muscle damage. When taking this medication with certain drugs (potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc.), the risk of side effects may increase due to interactions, so consultation with healthcare providers is necessary. Women who are pregnant or planning to become pregnant must consult their healthcare provider before taking this medication and employ appropriate contraception. Nursing mothers should consider stopping breastfeeding or discontinuing the medication due to potential adverse effects on the infant. Safety and efficacy have not been established for children under 18 years of age, so use is not recommended. Elderly patients may require dose adjustment due to potential increased drug concentration. In case of overdose, symptoms may include hypotension and palpitations, and appropriate medical treatment should be sought if necessary. This medication should be kept out of reach of children, and it should not be transferred to another container.
Urticaria, severe swelling (edema), angioedema, facial swelling, chest tightness, difficulty breathing, anaphylaxis, asthma attack, severe rash with fever, blisters, skin exfoliation, pain in mucous membranes of mouth/eyes, jaundice, autoimmune hepatitis, acute renal failure, very severe headache, seizures, confusion, visual disturbances, paralysis, severe edema, markedly decreased urine output, edema accompanied by increased blood pressure, multiple organ failure syndromes.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container, protected from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This storage method helps preserve the efficacy of the medication and prevent degradation.
White or pale yellow round film-coated tablet
30 tablets/box [30 tablets (10 tablets/Alu-Alu) ×3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd. Daewoong Pharmaceutical)
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.